Overcoming Barriers to CAR T Referral in R/R MM

featured-image

Experts discuss the challenges and barriers to early referral for chimeric antigen receptor (CAR) T-cell therapy, including logistical, financial, and patient-related factors that may impact timely access to treatment.

Video content above is prompted by the following:.